INTRODUCTION
Vibrio cholerae pathogenesis is multi-factorial and relies on both host and bacterial counterparts. V. cholerae after being introduced into the intestinal lumen requires attachment to intestinal linings. This initial attachment is the key step in pathogenesis of V. cholerae. N-Acetylglucosamine-binding protein A (GbpA), the gene product of locus VCA0811, serves an important role as a common adhesin for chitinous surfaces as well as intestinal epithelium (Kirn et al., 2005; Bhowmick et al., 2008; Wong et al., 2012) . It was identified as an adhesion factor for surfaces with N-acetylglucosamine (GlcNAc) and its oligomers (Meibom et al., 2004) . In spite of being secretory in nature, GbpA has been found to be the factor bridging V. cholerae and mucin in the host (Bhowmick et al., 2008) . The GbpA was found to increase the production of intestinal secretory mucins (MUC2, MUC3 and MUC5AC) in HT-29 cells through the activation of corresponding genes (Bhowmick et al., 2008) . The activation of mucin genes (MUC2 and MUC5AC) was found to be dependent on nuclear translocation of NF-kB (Bhowmick et al., 2008) . Therefore, GbpA can be considered as an effector molecule capable of eliciting host response.
Necrosis is a type of inflammatory cell death characterized by membrane rupture, nuclear disruption and the concomitant release of cellular contents. Necrotically dying cells can initiate pro-inflammatory signalling cascades by effectively releasing inflammatory cytokines and by spilling their cellular contents when they rupture. Reactive oxygen species (ROS) have been documented to be a major factor in the propagation of necrotic cell death (Festjens et al., 2006) . Necrosis can also be triggered by danger signals like externalization of phosphatidylserine (PS) on cell membrane, depletion of ATP molecules, mitochondrial dysfunction, etc., which can be induced upon bacterial infection (Golstein et al., 2007) . Host cell response including release of proinflammatory cytokines and cell death due to ROS generation are well described in the case of invasive Vibrio vulnificus infection (Lee et al., 2015a, b) . V. cholerae cytolysin was found to induce autophagy, vacuolation and apoptosis (Coelho et al., 2000; Gutierrez et al., 2007; Saka et al., 2008) as well as secretion of pro-inflammatory cytokine IL-8 (Ou et al., 2009) in cell culture models. However, there is a dearth of instances of ROS accumulation and cell necrosis in V. cholerae infection owing to the facts that V. cholerae is noninvasive in nature and cholera pathogenesis is unrelated to intestinal inflammation.
Until now, considerable progress in the characterization of GbpA has been made, yet little is known about its role in host response. In this current study, we investigated the role of V. cholerae GbpA in eliciting host response in HT-29 gastrointestinal cells. We report that GbpA treatment elicits host response in the form of cell necrosis, ROS generation and activation of NF-kB in tissue culture models (HT-29 cells).
METHODS
Bacterial strain and protein preparation. V. cholerae O1 El Tor strain N16961 was used to determine the amount of GbpA secreted in infected rabbit intestine. The bacteria were cultured in Luria-Bertani medium at 37 C. V. cholerae GbpA protein was expressed in BL21 Star (DE3) cells harbouring the pET22b vector encoding the gbpA gene (VCA0811), as described previously (Wong et al., 2012) .
Cell culture. Human intestinal cell line HT-29 was procured from NCCS. The cells were routinely maintained in DMEM (Dulbecco's Modified Eagle Medium) (Sigma) supplemented with 10 % foetal bovine serum, 100 U of penicillin ml À1 and 100 µg of streptomycin ml
À1
(MP Biomedicals) in 5 % CO 2 environment at 37 C.
Determination of amount of GbpA secreted in the rabbit intestine. The standard curve of GbpA was prepared by indirect ELISA method using 0.01-2 µg µl À1 of purified GbpA and 1 : 500 anti-GbpA antibody raised in mouse. The standard curve regression equation was generated from the curve. The amount of GbpA secreted from V. cholerae in adult rabbit intestine was determined using the ileal loop method, as reported previously (De et al., 1953) ; 10 8 c.f.u. of V. cholerae N16961 in 1 ml PBS was inoculated in a 10 cm loop. Fluid accumulated within the inoculated loop was collected for quantification of GbpA. The concentration of GbpA present in accumulated fluid was determined using the standard curve equation of GbpA.
Assessment of morphological changes. HT-29 cells treated with (250 ng µl

À1
) or without GbpA were incubated for 24 h. The morphological alterations in the GbpA-treated cells were observed under phase contrast microscope using Â40 objective (Zeiss). Cells were also imaged by fluorescence microscope (Zeiss) after immunostaining of actin cytoskeleton using anti-actin primary antibody and AlexaFluor 488-conjugated secondary antibody followed by counterstaining with 4', 6-diamidino-2-phenylindole (DAPI). Alterations in cell size and complexity in GbpA-treated cells were examined by flow cytometer under the parameters applicable for forward scattering (FSC) and side scattering (SSC), as described previously (Gupta et al., 2015) . Here, FSC correlates with the measure of cell size and shape, whereas SSC indicates relative cell granularity, refractivity and presence of intra-cellular structures that can reflect the light. For this study, cells treated with or without GbpA were re-suspended in the staining buffer containing 0.1 mg ml À1 propidium iodide (PI) in 0.6 % Triton-X in PBS and washed twice with PBS before fluorescence-activated cell sorting (FACS) analysis.
MTT-cell viability assay. In this assay, 5Â10 4 HT-29 cells well À1 were seeded in 96-well plates and treated with increasing concentration of GbpA for 24 h. Untreated cells were kept as control. Cell viability was determined by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT)-based cell growth determination kit (Promokine) as per recommended protocol.
Lactate dehydrogenase release assay. HT-29 cells (5Â10 4 well À1 ) were seeded in a 96-well plate and treated with GbpA according to the protocol mentioned in MTT assay. The release of lactate dehydrogenase (LDH) in the culture supernatant was monitored by colorimetric method using the LDH Cytotoxicity assay kit (Takara Bio) following the manufacturer's protocol.
FACS-based annexin V-FITC/PI double staining assay. GbpAtreated HT-29 cells were double stained using annexin V-FITC/PI (BD Biosciences), and the percentage of cell population undergoing flipping of PS was evaluated using flow cytometer. Untreated cells were kept as control. For flow cytometer analysis, data acquisition was conducted on a FACS Aria cytometer using a FACS Diva data management system (BD Biosciences).
DNA ladder assay. The effect of GbpA treatment on nuclear DNA of HT-29 cells was detected by DNA ladder assay using the DNA ladder isolation kit (Abcam). Cells treated with H 2 O 2 were taken as positive control for cell necrosis. Untreated cells were set up as negative control.
TUNEL staining. The physical status of the cell nucleus upon GbpA treatment was evaluated by terminal deoxynucleotidyl transferase-mediated dUTP nick end labelling (TUNEL) staining using the APO Direct kit (BD Biosciences). After treatment for 24 h, cells were subjected to dual staining with TUNEL and PI as stated in the kit protocol. TUNELstained cells were monitored by fluorescence microscopy under oil immersion objective.
Detection of ROS and mito-ROS. To determine total intra-cellular ROS and mito-ROS, fluorescence microscopy and flow cytometer analysis were carried out. Cells were treated with GbpA (250 ng µl
) and incubated for 8 h at 37 C. The cells were washed with PBS and incubated with 2¢,7¢-dichlorofluorescein diacetate (H2-DCFDA; Abcam) at a final concentration of 40 µM. For flow cytometer examination, a FACS Canto II cytometer (BD Biosciences) was used. Cells treated with GbpA in presence of N-acetyl-L-cysteine (NAC) were set up as experimental control to determine the specificity of GbpA in provoking ROS generation in host cells. MitoSOX (Invitrogen) was used to detect mitochondrial ROS at a final concentration of 10 µM in serum-deficient DMEM in GbpA-treated cells incubated for 30 min at 37 C. Apocynin , were coated in the wells of microtitre plate, and amount of colour developed was quantified using polyclonal anti-GbpA raised in mouse at a dilution of 1: 500 by measuring the absorbance at 450 nm. (b) GbpA induces loss in cell viability. Estimation of viability of HT-29 cells upon treatment with increasing concentration of GbpA for 24 h was monitored by the MTT-based assay. The bar diagram represents the mean±SE of three independent measurements.
(Santa Cruz), an inhibitor of non-mitochondrial ROS generation, was used to confirm mitochondria as the major source ROS in target cells. For fluorescence microscopy study, the cells were mounted with ProLong Gold Anti-fade Reagent with DAPI (Invitrogen), and images were recorded using a confocal microscope (LSM710; Carl Zeiss) at Â63 magnification. To directly monitor the ROS production in live cells using fluorescence microscopy, a Cellular ROS Detection Assay kit was used (Abcam). NAC was used to inhibit ROS production wherever applicable. All data shown are illustrative of three independent experiments.
Nuclear and cytoplasmic protein extraction and immunoblot analysis. The HT-29 cells were ruptured in equal volumes of ice-cold lysis buffer containing protease inhibitor cocktail. Nuclear and cytoplasmic extracts were isolated using NE-PER Nuclear and Cytoplasmic Extraction Reagents (Thermo Fisher Scientific) according to manufacturer's provided protocol. The extracts were subjected to SDS-PAGE and blotted onto nitrocellulose membranes. In each case, 30 µg of total protein was loaded in each well. After probing with specific primary (Cell Signaling Technology) and secondary antibodies (Sigma), membranes were developed with ECL system (Millipore). Immunofluorescence assay to detect the nuclear translocation of NF-kB. Samples were prepared as described previously (Yuan et al., 2013) with little modifications. Briefly, cells were seeded on the coverslips and grown overnight and treated with GbpA (250 ng µl
) for 45 min. Cells were then incubated with primary antibodies against NF-k B-p65 (Cell Signaling Technology) diluted in PBS (1 : 400) for overnight at 4 C. Cells were washed thrice in PBS and incubated with Alexa Fluor 488-conjugated secondary antibody (Abcam) for 1 h. The cells were mounted with ProLong Gold Anti-fade Reagent having DAPI (Invitrogen) as a counterstain. Images were acquired in a confocal microscope (LSM 710; Carl Zeiss) at 63Â magnification. MG-132 (1 µM) served as inhibitor of NF-kB activation, and the cells were processed identically following GbpA treatment. Cells pre-treated with NAC were also stained for imaging purposes. ) or without GbpA were stained with JC-1 (BD Biosciences) and were subjected to fluorescence microscopy. The data are represented as the ratio of red to green fluorescence intensity. A decrease in the ratio of red/ green in GbpA-treated cells compared to that of untreated cells is considered a reduction in MMP (D m ).
Statistical analysis. Most of the experiments were executed in triplicate. Data are represented as means±SE. The data are analysed by oneway ANOVA applying GraphPad Prism version 5.0 for Windows. P<0.05 was considered statistically significant.
RESULTS
V. cholerae secretes a significant amount of GbpA in the rabbit intestine
The regression equation obtained from the standard curve of GbpA was used to calculate the amount of GbpA secreted in the rabbit intestine (Fig. 1a) . The concentration of GbpA was found to be 330 ng µl À1 in the rabbit ileal loop assay. 
GbpA treatment induces dose-dependent death of intestinal cells
HT-29 cells were treated with different concentrations of GbpA for 24 h, and cell viability was examined using MTT assay. The result showed that the cells lost viability with increasing doses of GbpA (Fig. 1b) . In response to 35 ng µl À1 of GbpA, 25 % loss of cell viability was observed. Loss in cell viability was 50 and 75 % with treatments of 250 and 500 ng µl À1 of GbpA, respectively. Untreated cells were 100 % viable. These observations suggested that GbpA treatment impaired target cell health and induced loss in cell viability.
GbpA induces morphological distortions in host cells that indicate necrosis
The effect of GbpA on the morphology of HT-29 cells was examined. Rounding of cells, poor adherence and appearance of cell debris revealed the necrotizing effect of GbpA on intestinal cells. Untreated cells were intact in cell morphology (Fig. 2a) . Alteration in the arrangement of actin filaments in HT-29 cells treated with GbpA was visualized by fluorescence staining of cytoskeleton. The untreated cells were rich in actin filaments with regular parallel organization, and cell morphology appeared intact. Treatment with GbpA for 24 h caused perturbation of cytoskeletal organization. The actin filaments became disordered and chaotic in appearance and the cell morphology indicated features of cell necrosis (Fig. 2b) .
The changes in cell morphology, observed under phase and fluorescence microscopy, were further confirmed by flow cytometry as dot plots of dual parameters FSC vs SSC (cell size vs granularity, density). Comparative analysis by bi-parametric system (dot plot) of FSC vs SSC for cells treated with GbpA showed a distinct shift of the main cell population towards the Y-axis (i.e. SSC) (Fig. 2c) . This implied a decrease in FSC and an increase in SSC. This suggested that GbpA induces shrinkage of cell size and shape (FSC) along with increased relative cell granularity (SSC) in target cells, which was found quite consistent with the earlier imaging results.
GbpA treatment leads to externalization of PS in target cell membrane
The effect of GbpA treatment on the biochemical changes in the host cell membrane was evaluated by the detection of externalized PS on the outer leaflet of cell membrane. To examine GbpA-induced flipping of PS in target cell membrane, the HT-29 cells were treated with different doses of GbpA and incubated for 24 h. In the flow cytometry experiment, GbpA-treated cells were annexin V/PI double positive. This population increased in a dose-dependent manner from 125 to 1000 ng µl À1 of GbpA (Fig. 3) . Treatment with 125 ng µl -1 of GbpA gave rise to 28 % late apoptotic cells. Treatment with 1000 ng µl À1 of GbpA gave rise to 60 % late apoptotic cells. 
GbpA induces DNA damage in target cells typical of necrotic cells
The integrity of DNA of target cells following GbpA treatment was tested by DNA ladder assay and TUNEL staining. The resulting agarose gel from the DNA ladder assay from the 8 and 24 h post-incubation samples showed a DNA smearing pattern. H 2 O 2 -treated cells, which were used as positive control for DNA damage, demonstrated a similar pattern. This type of DNA smearing is a typical pattern in necrotic cells. In the case of untreated cells, intact genomic DNA was observed (Fig. 4a) . The deterioration in DNA integrity induced by GbpA treatment was further probed by TUNEL staining. We found TUNEL-positive cells in the treatment group, whereas untreated cells appeared TUNEL negative (Fig. 4b) .
GbpA induces increased cell membrane permeability
Next, LDH release assay was done to analyse cell membrane leakage during GbpA treatment. Different doses of GbpA were used to treat HT-29 cells for 24 h and the supernatants were collected. Supernatants were assessed for the release of LDH. The result obtained showed a significant spillage of LDH, indicating cell membrane rupture in GbpA-treated cells (42 % at a concentration of 250 ng µl
À1
) with respect to untreated cells (Fig. 5) . The above results led to the conclusion that GbpA-mediated cell death could have characteristics of necrosis.
GbpA elicits mitochondrial ROS accumulation in host cells
Since the results obtained so far were indicative of necrotic cell death, accumulation of intra-cellular ROS in host cells was measured. Results showed that untreated cells had low levels of spontaneous ROS, whereas GbpA at a concentration of 250 ng µl À1 augmented the ROS production by approximately fourfold (P<0.05). Pre-treatment of cells with NAC (an ROS scavenger) for 1 h inhibited the intracellular ROS accumulation in GbpA-treated cells (Fig. 6a) . Fluorescence microscopy results showed that GbpA increased ROS and superoxide production in cells compared to cells without any treatment. NAC treatment prior to GbpA stimulation effectively reduced the ROS and superoxide accumulation in the cells (Fig. 6b) .
Next, the HT-29 cells were stained for mito-ROS using MitoSOX dye and with Z (DCFDA) to detect the cellular ROS concomitantly. The confocal images showed red fluorescence from mito-ROS co-localized with the green fluorescence of DCF-ROS in GbpA-treated cells. In the case of untreated cells, only background fluorescence of DCF was detected. Apocynin, an inhibitor of non-mitochondrial ROS production, showed no effect on the GbpA-mediated ROS accumulation. This suggested that the mitochondrial ROS were the main contributor to ROS (Fig. 6c) .
GbpA induces mitochondrial dysfunction in target cells
In order to understand whether the GbpA-mediated cell death mechanism involved mitochondrial dysfunction, HT-29 cells were treated with different doses of GbpA. Treated cells were examined for alteration in MMP (D m ), using Mitotracker Red CMXros dye. The result showed that the uptake of the dye gradually decreased compared to untreated cells. Valinomycin-treated cells served as positive control and showed similar pattern in the uptake of the dye (Fig. 7a, b) .
The depolarization of MMP was further confirmed by staining the GbpA-treated cells with JC-1 dye. The fluorescence images indicated that the red J-aggregates converted into green J-monomers upon stimulation with GbpA. The result showed a decrease of the ratio of red to green fluorescence following GbpA treatment. Red to green fluorescence ratio in untreated cells was 0.8 and decreased to 0.6 in GbpAtreated cells (P<0.05) (Fig. 7c) .
Mitochondrial dysfunction often leads to decrease in cellular ATP level. The cellular content of ATP following GbpA treatment was estimated. The result suggested that GbpA treatment caused about twofold reduction (P<0.05) in ATP level compared to the untreated cells (Fig. 7d) .
GbpA induces nuclear translocation of NF-kB-p65 in host cells
Following GbpA treatment, activation of NF-kB in response to GbpA was evaluated. The confocal images of HT-29 cells stained for NF-kB-p65 indicated that the protein was mainly sequestered in the cytosol in untreated cells. Treatment of cells with GbpA led to the migration of NF-kB-p65 from cytosol to nucleus within 45 min post-stimulation. The NF-kB inhibitor MG-132, blocked the activation of GbpA-induced NF-kB activation (Fig. 8a) .
Influence of ROS on NF-kB activation in GbpAtreated cells
Next, we looked into whether the intra-cellular ROS accumulated in response to GbpA could influence the nuclear translocation of NF-kB in target cells. The effect of intracellular ROS in the translocation of NF-kB-p65 was investigated by neutralizing the ROS with antioxidant NAC. The confocal images indicated that pre-treatment of cells with NAC for 1 h blocked the migration of NF-kB-p65 from cytosol to nucleus (Fig. 8b) . The immunoblots of cytosolic and nuclear extracts from HT-29 cells stimulated with GbpA further confirmed the successive changes in localization of the NF-kB-p65 protein. Here, it was also found that pre-treatment of cells with NAC inhibited the translocation process (Fig. 8c) .
DISCUSSION
Results presented here showed that GbpA can induce necrotic cell death in intestinal cells. Different bacterial proteins can induce a number of host cellular responses, and cell death is one of them. A study on V. cholerae porin OmpU suggested that it has the ability to induce target cell death (Gupta et al., 2015) . Recently, a group reported that outer membrane vesicle associated biologically active proteases from V. cholerae can induce cytotoxic and inflammatory response in host cells (Mondal et al., 2016) . A recent report on V. cholerae haemagglutinin protease suggested effective apoptosis of breast cancer cells (Ray et al., 2016) . These emerging reports on targeted cell death by V. cholerae proteins suggest that our observation of cell death induced by GbpA is also possible.
Further insights into the mechanism of cell death induced by GbpA revealed characteristics of necrosis. In healthy cells, PS molecules are distributed asymmetrically on the cell membrane and majorly found in abundance in the inner cell membrane. In cells undergoing necrosis, PS externalization takes place owing to membrane blebbing, and its availability increases in the outer leaflet of the cell membrane (Zao et al., 2015) . Our data also indicated that GbpA induces externalization of PS in intestinal cells.
Increase in cell membrane permeability indicates compromised cell membrane integrity. This leads to the spillage of cellular contents in the extra-cellular milieu which might provoke inflammatory reactions in neighbouring cells (Matzinger, 1994; Shi et al., 2000) . Here, presence of GbpA was found to increase cell membrane permeability in host cells which is indicative of cell necrosis.
The integrity of cellular DNA reflects the physical status of host cells. In apoptotic cells, DNA fragmentation takes place which appears as a DNA ladder in ladder assay ( Ioannou & Chen, 1996; Suman et al., 2012) . On the contrary, in necrotic cells, DNA is cleaved into fragments of random size by non-specific lysosomal nucleases that generate a DNA smear on agarose gel electrophoresis. Here, the occurrence of smearing pattern of DNA isolated from the GbpA-treated cells indicates cell necrosis. Appearance of TUNEL-positive cells further strengthened our hypothesis of GbpA-induced necrotic cell death. Bacterial components have been found to trigger host cell death with some features of necrosis (Lamkanfi et al., 2010) .
GbpA exposure could also elicit accumulation of intra-cellular ROS in host cells. An earlier study showed that V. cholerae infection stimulates ROS production in human neutrophils (Seper et al., 2013) . Furthermore, the mitochondria of cells were the main contributor of ROS generation. GbpA-mediated ROS generation suggested that it could induce mitochondrial dysfunction and depletion of ATP pool. Depolarization of MMP usually affects the electron transport chain which may result in the generation of ROS and depletion of ATP pool in affected cells (Kirkinezos et al., 2001; Trancíkov a et al., 2004) . Our results also indicated ATP depletion in GbpA-treated cells.
Previous reports have shown a correlation between ROS production and functional deterioration and progression in necrotic cell death (Morgan et al., 2008; Simon et al., 2009; Choi et al., 2009) . Similar types of events was also observed in this study. Thus, it can be extrapolated that the ROS generation following GbpA exposure could contribute to the cell necrosis.
Another significant finding of our study was the activation of transcription factor NF-kB. Previously, it was demonstrated that the induction of mucin genes (Bhowmick et al., 2008) and secretion of pro-inflammatory cytokine IL-8 in intestinal cells by GbpA were regulated by NF-kB. Further influence of ROS on NF-kB activation induced by various environmental stimuli is reported. However, the relationship of ROS and NF-kB activation pathway has been found to be quite complex and multi-faceted (Lang et al., 2000; Montiel-Duarte et al., 2004; Saile et al., 2001) . NF-kB-inducing kinase and IKKa/ IKKb are reported as key kinases and act in a cascade to activate the NF-kB pathway (Tang et al., 2004) . Study revealed that increased endogenous ROS facilitates the activation of NF-kB-inducing kinase and subsequent phosphorylation of IKKa and IKKb as well as degradation of IKBa which, in turn, results in the activation of NF-kB (Wang et al., 2007) . Studies have also delineated the signalling pathways leading to NF-kB activation by H 2 O 2 in HeLa cells (Storz et al., 2003 (Storz et al., , 2004 where H 2 O 2 induces IKKb activation and NF-kB transcriptional activity via activation of protein kinase D. Here, the activation of NF-kB by GbpA was found to be dependent on the ROS, since ROS scavenger NAC effectively inhibited the process. Therefore, it can be assumed that the similar signalling events in intestinal epithelial cells might occur to accomplish the NF-kB activation in presence of GbpA through the involvement of endogenous ROS.
Collectively, it can be said that GbpA is an active bacterial component eliciting host response in the form of necrotic cell death characterized by cellular DNA damage, PS flipping, leaky cell membrane, cell rounding and increased cell granularity. Moreover, GbpA was found to induce mitochondrial dysfunction characterized by decrease in MMP, depletion in ATP content and accumulation of intra-cellular ROS in intestinal cells. Additionally, it was demonstrated that GbpA-induced activation of NF-kB was closely linked with the ROS generation.
V. cholerae is non-invasive, and necrotic cells are rarely visible in biopsy samples from cholera patients. Therefore, any possible intestinal tissue damage due to necrosis may be replenished readily beyond its detection, since cholera is a self-limiting disease. Another possible explanation for nonavailability of necrotic cells after bacterial infection may be that the necrotic cell corpses are readily engulfed by the sensitized surveillance cells at the site of infection. Further studies are required to understand the intestinal tissue damage during V. cholerae pathogenesis.
Sequencing analysis of the 488 V. cholerae strains, originating from different cholera-affected regions in the world, suggests that the gbpA gene is highly conserved within the species (Stauder et al., 2012) . Interestingly, the gene is also present in environmental strains belonging to other Vibrio spp. including Vibrio alginolyticus, Vibrio metschnikovii, Vibrio mimicus, V. vulnificus and Vibrio parahaemolyticus. Recent report suggested that, in V. vulnificus, the mucinbinding protein GbpA is essential for pathogenesis (Kyung et al., 2016) . BLAST analysis with V. vulnificus GbpA revealed 76 % sequence similarity in protein level with that of V. cholerae. Additionally, GbpA-like proteins are present in several other pathogenic, non-Vibrio bacteria, such as Listeria monocytogenes, Bacillus cereus and Yersinia pestis (Loose et al., 2014) . Therefore, it can be speculated that the GbpA and GbpA-like proteins are ubiquitous in Vibrio as well as in other pathogenic organisms and likely to function in a similar way.
